Pharmaceutical industry news
Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.
43,878 stories, page 576 of 732
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry
NCT05038735: Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
Study type: INTERVENTIONAL. Phase: PHASE3.
ClinicalTrials.govOriginal source






